US 2025/0325501 A1Published application

A sphingosine-1-phosphate receptor (s1pr) modulator for use in treating a patient suffering from alzheimer's dementia

AssigneeOtto-Von-Guericke-Universitaet Magdeburg

InventorsVolkmar Lessmann, Kurt Gottmann, Thomas Endres, Georgia-Ioanna Kartalou

Life of this patent

Estimating the term…

Abstract

The present invention relates to a sphingosine-1-phosphate receptor (S1PR) modulator for use in treating a patient suffering from Alzheimer's dementia.

Claims18

Dependent claims

A sphingosine-1-phosphate receptor (S1PR) modulator for use in treating a patient suffering from Alzheimer's dementia.

Dependencies are inferred from the claim text.

Facts

Application: 18/852,464Filed 30 Mar 2023
Priority: EP 22166162.231 Mar 2022
Published: 23 Oct 2025
Term ends: Not estimatedThe source records don’t support an estimate.

Classification9 codes

A61K 31/137
Having aromatic rings , e.g. ketamine, nortriptyline: arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
A61K 31/397
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having four-membered rings, e.g. azetidine
A61K 31/4245
Having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole: oxadiazoles
A61K 31/426
Thiazoles: 1,3-Thiazoles

Family

No related US applications are recorded in the indexed filing history.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…